Drug Shortage Report for LEUCOVORIN CALCIUM INJECTION

Last updated on 2025-03-28 History
Report ID 245598
Drug Identification Number 02087316
Brand name LEUCOVORIN CALCIUM INJECTION
Common or Proper name LEUCOVORIN CALCIUM INJ 10MG/ML
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) LEUCOVORIN
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 50ml
ATC code V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-12-11
Estimated end date 2025-03-01
Actual end date 2025-03-26
Shortage status Resolved
Updated date 2025-03-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2025-03-28 French Compare
v8 2025-03-28 French Compare
v7 2025-03-28 English Compare
v6 2025-01-17 French Compare
v5 2025-01-17 English Compare
v4 2024-12-20 French Compare
v3 2024-12-20 English Compare
v2 2024-12-13 French Compare
v1 2024-12-13 English Compare

Showing 1 to 9 of 9